Isaura S Ibrahim Bert A Bonsing Rutger-Jan Swijnenburg Lieke Welling Roeland A Veenendaal Martin N J M Wasser Hans Morreau Akin Inderson Hans F A Vasen
10.1007/s10689-016-9915-3
Fam Cancer
2017 Jan;16(1):111-115.
cdkn2a mutation complications genetic predisposition pdac pancreatic ductal adenocarcinoma pylorus-preserving pancreaticoduodenectomy surveillance p16-leiden mutation
CC BY
https://pubmed.ncbi.nlm.nih.gov/27406244/
Carcinoma, Pancreatic Ductal / diagnostic imaging Pancreatic Neoplasms / diagnostic imaging
Carcinoma, Pancreatic Ductal / diagnostic imaging Pancreatic Neoplasms / diagnostic imaging Case Reports Carcinoma, Pancreatic Ductal / genetics Carcinoma, Pancreatic Ductal / pathology Cyclin-Dependent Kinase Inhibitor p16 Cyclin-Dependent Kinase Inhibitor p18 / genetics Heterozygote Humans Magnetic Resonance Imaging Male Middle Aged Pancreatic Neoplasms / genetics Pancreatic Neoplasms / pathology Tomography, X-Ray Computed CDKN2A protein, human Cyclin-Dependent Kinase Inhibitor p16 Cyclin-Dependent Kinase Inhibitor p18
PMC5243878
27406244
Dilemmas in the management of screen-detected lesions in patients at high risk for pancreatic cancer
2017